Decoding the anti-obesity mechanisms of isoliquiritigenin: AMPK activation modulates adipogenesis, lipolysis, oxidative stress, and inflammation in high-fat diet rat models
Open Access
- 20 November 2025
- journal article
- Published by Elsevier in The Journal of Nutritional Biochemistry
- Vol. 149, 110190
Abstract
No abstract availableKeywords
Funding Information
- Princess Nourah Bint Abdulrahman University (PNURSP2025R257)
This publication has 80 references indexed in Scilit:
- An insight into the therapeutic effects of isoliquiritigenin in breast cancerNaunyn-Schmiedeberg's Archives of Pharmacology, 2024
- AMP‐activated protein kinase is a key regulator of obesity‐associated factorsCell Biochemistry and Function, 2022
- Administration of isoliquiritigenin prevents nonalcoholic fatty liver disease through a novel IQGAP2‐CREB‐SIRT1 axisPhytotherapy Research, 2021
- AMPK α1 mediates the protective effect of adiponectin against insulin resistance in INS‐1 pancreatic β cellsCell Biochemistry and Function, 2019
- Isoliquiritigenin impairs insulin signaling and adipocyte differentiation through the inhibition of protein-tyrosine phosphatase 1B oxidation in 3T3-L1 preadipocytesFood and Chemical Toxicology, 2016
- The effect of isoliquiritigenin on learning and memory impairments induced by high-fat diet via inhibiting TNF-α/JNK/IRS signalingBiochemical and Biophysical Research Communications, 2015
- A Redox-Dependent Mechanism for Regulation of AMPK Activation by Thioredoxin1 during Energy StarvationCell Metabolism, 2014
- AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespanJournal of Molecular Medicine, 2011
- Inhibition of liver X receptor-α-dependent hepatic steatosis by isoliquiritigenin, a licorice antioxidant flavonoid, as mediated by JNK1 inhibitionFree Radical Biology and Medicine, 2010
- Transcriptional control of adipocyte formationCell Metabolism, 2006